Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


1 Ann Surg Oncol
1 Anticancer Res
1 Biomed Pharmacother
1 Expert Rev Mol Diagn
1 Histochem Cell Biol
2 Mol Cancer Ther
1 Oncoimmunology
2 Oncotarget
1 Photochem Photobiol Sci
1 Photomed Laser Surg
1 Trials
1 Urol Oncol
1 World J Urol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Surg Oncol

  1. FUKUMOTO K, Kikuchi E, Mikami S, Hayakawa N, et al
    Clinical Role of Programmed Cell Death-1 Expression in Patients with Non-muscle-invasive Bladder Cancer Recurring After Initial Bacillus Calmette-Guerin Therapy.
    Ann Surg Oncol. 2018 May 1. pii: 10.1245/s10434-018-6498.
    PubMed     Text format     Abstract available

    Anticancer Res

  2. REXIN P, Tauchert A, Hanze J, Heers H, et al
    The Immune Checkpoint Molecule CD200 Is Associated with Tumor Grading and Metastasis in Bladder Cancer.
    Anticancer Res. 2018;38:2749-2754.
    PubMed     Text format     Abstract available

    Biomed Pharmacother

  3. CHENG J, Chen J, Zhang X, Mei H, et al
    Overexpression of CRNDE promotes the progression of bladder cancer.
    Biomed Pharmacother. 2018;99:638-644.
    PubMed     Text format     Abstract available

    Expert Rev Mol Diagn

  4. MAAS M, Walz S, Stuhler V, Aufderklamm S, et al
    Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer.
    Expert Rev Mol Diagn. 2018 Apr 30. doi: 10.1080/14737159.2018.1469979.
    PubMed     Text format     Abstract available

    Histochem Cell Biol

  5. LOJK J, Bregar VB, Strojan K, Hudoklin S, et al
    Increased endocytosis of magnetic nanoparticles into cancerous urothelial cells versus normal urothelial cells.
    Histochem Cell Biol. 2018;149:45-59.
    PubMed     Text format     Abstract available

    Mol Cancer Ther

  6. KOUTSIOUMPA M, Chen HW, O'Brien N, Koinis F, et al
    MKAD-21 suppresses the oncogenic activity of the miR-21/PPP2R2A/ERK molecular network in bladder cancer.
    Mol Cancer Ther. 2018 Apr 27. pii: 1535-7163.MCT-17-1049.
    PubMed     Text format     Abstract available

  7. IDE H, Inoue S, Mizushima T, Jiang G, et al
    Androgen Receptor Signaling Reduces Radiosensitivity in Bladder Cancer.
    Mol Cancer Ther. 2018 May 2. pii: 1535-7163.MCT-17-1061.
    PubMed     Text format     Abstract available


  8. SHIMIZU T, Tomogane M, Miyashita M, Ukimura O, et al
    Low dose gemcitabine increases the cytotoxicity of human Vgamma9Vdelta2 T cells in bladder cancer cells in vitro and in an orthotopic xenograft model.
    Oncoimmunology. 2018;7:e1424671.
    PubMed     Text format     Abstract available


  9. TANG G, Zhen Y, Xie W, Wang Y, et al
    Preoperative hemoglobin-platelet ratio can significantly predict progression and mortality outcomes in patients with T1G3 bladder cancer undergoing transurethral resection of bladder tumor.
    Oncotarget. 2018;9:18627-18636.
    PubMed     Text format     Abstract available

  10. NAGAYA T, Okuyama S, Ogata F, Maruoka Y, et al
    Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibody.
    Oncotarget. 2018;9:19026-19038.
    PubMed     Text format     Abstract available

    Photochem Photobiol Sci

  11. KIM D, Lee MH, Koo MA, Kwon BJ, et al
    Suppression of T24 human bladder cancer cells by ROS from locally delivered hematoporphyrin-containing polyurethane films.
    Photochem Photobiol Sci. 2018 May 2. doi: 10.1039/c7pp00424.
    PubMed     Text format     Abstract available

    Photomed Laser Surg

  12. LU M, Liu X
    Comparison of GreenLight Laser Photoselective Vaporization and Thulium Laser Enucleation for Nonmuscle Invasive Bladder Cancer.
    Photomed Laser Surg. 2018 May 2. doi: 10.1089/pho.2018.4440.
    PubMed     Text format     Abstract available


  13. BREAU RH, Lavallee LT, Cnossen S, Witiuk K, et al
    Tranexamic Acid versus Placebo to Prevent Blood Transfusion during Radical Cystectomy for Bladder Cancer (TACT): Study Protocol for a Randomized Controlled Trial.
    Trials. 2018;19:261.
    PubMed     Text format     Abstract available

    Urol Oncol

  14. KWAN ML, Garren B, Nielsen ME, Tang L, et al
    Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer.
    Urol Oncol. 2018 Apr 24. pii: S1078-1439(18)30115.
    PubMed     Text format     Abstract available

    World J Urol

  15. PALOU J, Pisano F, Sylvester R, Joniau S, et al
    Recurrence, progression and cancer-specific mortality according to stage at re-TUR in T1G3 bladder cancer patients treated with BCG: not as bad as previously thought.
    World J Urol. 2018 May 2. pii: 10.1007/s00345-018-2299.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.